Tag: bioequivalence
Brand-to-Generic Switches: What Clinical Studies Really Say About Safety
Clinical studies reveal that while generic drugs are safe for most, switching from brand-name meds can pose risks for narrow therapeutic index drugs like antiepileptics. Learn what the data says about bioequivalence, side effects, and how to manage switches safely.
How to Build Patient Confidence in Generic Medications: Research-Backed Strategies
Learn research-based strategies to improve patient confidence in generic medications, focusing on bioequivalence, provider communication, and addressing demographic barriers.
How to Improve Patient Confidence in Generic Medications: Research-Based Strategies
Learn research-backed strategies to boost patient trust in generic drugs, focusing on FDA bioequivalence standards and effective provider communication.
Perception vs Reality: Why Generics Seem Less Effective
Explore the psychology behind why generic medications often feel less effective than brand-name drugs despite being chemically identical and FDA-approved.
Dissolution Testing: How the FDA Ensures Generic Drug Quality
The FDA uses dissolution testing to ensure generic drugs release their active ingredients at the same rate as brand-name versions, replacing costly human trials with reliable lab data. This science-based method keeps generics safe, effective, and affordable.